Fresenius Kabi Ipsum Srl, based in Italy, is a pharmaceutical company.
One of their notable products is CEFEPIME HYDROCHLORIDE STERILE, with a corresponding US DMF Number 27971.
Remarkably, this DMF maintains an Active status since its submission on January 20, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 01, 2014, and payment made on March 04, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II